Denız Can Guven

101PUBLICATIONS

317CO-AUTHORS

Molecular targetsLiquid biopsiesPredictive and prognostic markersArtificial life and complex adaptive systemsClinical midwifery

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (101)

Sort by Publication Date:

|Jun 25, 2026

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 08, 2026

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026

Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Mar 23, 2026

Artificial intelligence in cancer screening: a narrative review of current evidence and future directions.

Yigit Yazarkan, Gamze Sonmez, Taha Koray Sahin

|Mar 16, 2026

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.

Taha Koray Sahin, Fatih Kemik, Harun Muglu

|Mar 09, 2026

Harnessing the power of artificial intelligence for clinical trials in cancer.

Gamze Sonmez, Yigit Yazarkan, Taha Koray Sahin

Pageof 17

Frequent Collaborators

22 joint publications

Taha Koray Sahın

11 joint publications

Hasan Çağrı Yıldırım

11 joint publications

Sercan Aksoy

10 joint publications

Sadettin Kılıçkap

10 joint publications

Elif Sahin

Nargiz Majidova

Onur Bas

Havva Yeşil Çınkır

Omer Dizdar

Mustafa Erman

Frequent Collaborators

22 joint publications

Taha Koray Sahın

11 joint publications

Hasan Çağrı Yıldırım

11 joint publications

Sercan Aksoy

10 joint publications

Sadettin Kılıçkap